VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $130,000 | -45.8% | 27,449 | -18.4% | 0.00% | – |
| Q4 2020 | $240,000 | -6.6% | 33,643 | +40.0% | 0.00% | – |
| Q3 2020 | $257,000 | -66.0% | 24,034 | -59.9% | 0.00% | -100.0% |
| Q2 2020 | $756,000 | +206.1% | 59,946 | +122.7% | 0.00% | – |
| Q1 2020 | $247,000 | -46.4% | 26,917 | -18.5% | 0.00% | – |
| Q4 2019 | $461,000 | +31.7% | 33,028 | +62.6% | 0.00% | – |
| Q3 2019 | $350,000 | -28.3% | 20,315 | +13.1% | 0.00% | – |
| Q2 2019 | $488,000 | +91.4% | 17,961 | +35.3% | 0.00% | – |
| Q1 2019 | $255,000 | +110.7% | 13,276 | +2.1% | 0.00% | – |
| Q4 2018 | $121,000 | -54.2% | 13,002 | -3.5% | 0.00% | – |
| Q2 2018 | $264,000 | +2.7% | 13,474 | -1.7% | 0.00% | – |
| Q1 2018 | $257,000 | +13.7% | 13,706 | +25.0% | 0.00% | – |
| Q3 2017 | $226,000 | – | 10,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
| Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
| ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
| BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
| HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
| Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
| Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |